(Q35993424)

11 August 2017

4-Hydroxyandrostenedione in the prophylaxis of N-methyl-N-nitrosourea induced mammary tumourigenesis (English)

1 reference

11 August 2017

5

Easton DF

1 reference

11 August 2017

Coombes RC

1

1 reference

11 August 2017

Wilkinson JR

2

1 reference

11 August 2017

Bliss JM

3

1 reference

11 August 2017

Shah P

4

1 reference

11 August 2017

Dowsett M

6

1 reference

11 August 2017

language of work or name

English

0 references

publication date

1 August 1991

1 reference

British Journal of Cancer

11 August 2017

1 reference

11 August 2017

64

1 reference

11 August 2017

2

1 reference

11 August 2017

247-250

1 reference

https://scigraph.springernature.com/pub.10.1038/bjc.1991.285

11 August 2017

0 references

cites work

Menopause and breast cancer risk

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1977518

Treatment of advanced postmenopausal breast cancer with an aromatase inhibitor, 4-hydroxyandrostenedione: phase II report

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1977518

A pilot trial to evaluate the acute toxicity and feasibility of tamoxifen for prevention of breast cancer

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1977518

The endocrine prevention of breast cancer

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1977518

The clinical and endocrine effects of 4-hydroxyandrostenedione alone and in combination with goserelin in premenopausal women with advanced breast cancer

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1977518

4-Hydroxyandrostenedione in treatment of postmenopausal patients with advanced breast cancer

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1977518

Response of nitrosomethylurea-induced rat mammary tumor to endocrine therapy and comparison with clinical response

11 July 2018

1 reference

12 December 2020

Preliminary study of the treatment of advanced breast cancer in postmenopausal women with the aromatase inhibitor CGS 16949A

1 reference

12 December 2020

N-methyl-N-nitrosourea-induced rat mammary tumors. Hormone responsiveness but lack of spontaneous metastasis

1 reference

12 December 2020

Tamoxifen prophylaxis

1 reference

12 December 2020

CGS 16949A, a new nonsteroidal aromatase inhibitor: effects on hormone-dependent and -independent tumors in vivo

1 reference

12 December 2020

Identifiers

DOI

10.1038/BJC.1991.285

1 reference

Dimensions Publication ID

11 August 2017

0 references

1 reference

11 August 2017

PubMed publication ID

1892751

1 reference